337 related articles for article (PubMed ID: 16197649)
1. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
2. [Cardioprotective effects of anti-hypertensive medications].
Asmar RG
Curr Med Res Opin; 2005; 21 Suppl 5():S17-21. PubMed ID: 16197648
[TBL] [Abstract][Full Text] [Related]
3. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
4. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of therapeutic strategies in the management of hypertension].
Waeber B
Curr Med Res Opin; 2005; 21 Suppl 5():S13-6. PubMed ID: 16197647
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE
Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
[TBL] [Abstract][Full Text] [Related]
7. Perindopril + indapamide: new preparation. Simple trick.
Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
[TBL] [Abstract][Full Text] [Related]
8. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
9. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
10. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
11. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
12. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
13. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
14. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
[No Abstract] [Full Text] [Related]
15. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
[TBL] [Abstract][Full Text] [Related]
16. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
de Leeuw PW; ;
J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
[TBL] [Abstract][Full Text] [Related]
17. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Chalmers J; Neal B; MacMahon S;
J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
19. New Premier study suggest Preterax as a first-line antihypertensive.
Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
[No Abstract] [Full Text] [Related]
20. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
Holzgreve H
MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
[No Abstract] [Full Text] [Related]
[Next] [New Search]